Triple

Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).

Phrase: ICH S7A Safety Pharmacology Studies for Human Pharmaceuticals | Statement: [International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use, notableWork, ICH S7A Safety Pharmacology Studies for Human Pharmaceuticals]

Target entity: ICH S7A Safety Pharmacology Studies for Human Pharmaceuticals
Context triple: [International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use, notableWork, ICH S7A Safety Pharmacology Studies for Human Pharmaceuticals]

• A. Pharmacovigilance Risk Assessment Committee within the European Medicines Agency
  The Pharmacovigilance Risk Assessment Committee within the European Medicines Agency is an expert body responsible for evaluating and monitoring the safety of medicines across the European Union and providing recommendations on managing and communicating medicine-related risks.
• B. International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use
  The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) is a global body that develops and promotes unified scientific and technical standards to ensure the safety, quality, and efficacy of medicines worldwide.
• C. Center for Drug Evaluation and Research
  The Center for Drug Evaluation and Research is the U.S. FDA division responsible for overseeing the safety, effectiveness, and quality of prescription and over-the-counter drugs.
• D. ISO 14971
  ISO 14971 is an international standard that specifies a systematic process for risk management of medical devices throughout their life cycle.
• E. Committee for Proprietary Medicinal Products
  The Committee for Proprietary Medicinal Products was a former scientific committee of the European Union responsible for evaluating and issuing opinions on the quality, safety, and efficacy of human medicinal products before it was replaced by the European Medicines Agency’s current committee structure.
• F. None of above. chosen
• G. Unsure - the case is ambiguous/there is not enough information to decide.

Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"

Entity: ICH S7A Safety Pharmacology Studies for Human Pharmaceuticals
Triple: [International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use, notableWork, ICH S7A Safety Pharmacology Studies for Human Pharmaceuticals]

ICH S7A Safety Pharmacology Studies for Human Pharmaceuticals is an ICH guideline that outlines the core nonclinical safety pharmacology studies needed to evaluate the potential adverse effects of new drugs on vital physiological systems before human use.

Target entity: ICH S7A Safety Pharmacology Studies for Human Pharmaceuticals
Target entity description: ICH S7A Safety Pharmacology Studies for Human Pharmaceuticals is an ICH guideline that outlines the core nonclinical safety pharmacology studies needed to evaluate the potential adverse effects of new drugs on vital physiological systems before human use.

• A. Pharmacovigilance Risk Assessment Committee within the European Medicines Agency
  The Pharmacovigilance Risk Assessment Committee within the European Medicines Agency is an expert body responsible for evaluating and monitoring the safety of medicines across the European Union and providing recommendations on managing and communicating medicine-related risks.
• B. International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use chosen
  The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) is a global body that develops and promotes unified scientific and technical standards to ensure the safety, quality, and efficacy of medicines worldwide.
• C. Center for Drug Evaluation and Research
  The Center for Drug Evaluation and Research is the U.S. FDA division responsible for overseeing the safety, effectiveness, and quality of prescription and over-the-counter drugs.
• D. ISO 14971
  ISO 14971 is an international standard that specifies a systematic process for risk management of medical devices throughout their life cycle.
• E. Committee for Proprietary Medicinal Products
  The Committee for Proprietary Medicinal Products was a former scientific committee of the European Union responsible for evaluating and issuing opinions on the quality, safety, and efficacy of human medicinal products before it was replaced by the European Medicines Agency’s current committee structure.
• F. None of above.